var data={"title":"Clinical manifestations and diagnosis of Cryptococcus neoformans meningoencephalitis in HIV-seronegative patients","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Clinical manifestations and diagnosis of Cryptococcus neoformans meningoencephalitis in HIV-seronegative patients</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/contributors\" class=\"contributor contributor_credentials\">Gary M Cox, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/contributors\" class=\"contributor contributor_credentials\">John R Perfect, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/contributors\" class=\"contributor contributor_credentials\">Carol A Kauffman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/contributors\" class=\"contributor contributor_credentials\">Jennifer Mitty, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 07, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Cryptococcus neoformans</em> meningoencephalitis is the most frequently encountered manifestation of cryptococcosis. The term &quot;meningoencephalitis&quot; is more appropriate than &quot;meningitis&quot; since histopathological examination has demonstrated that the brain parenchyma is almost always involved.</p><p>Cryptococcal meningoencephalitis is an important opportunistic infection in immunosuppressed patients. Issues related to patients with HIV are discussed in detail separately. (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of Cryptococcus neoformans meningoencephalitis in HIV-infected patients&quot;</a> and <a href=\"topic.htm?path=treatment-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Treatment of Cryptococcus neoformans meningoencephalitis in HIV-infected patients&quot;</a> and <a href=\"topic.htm?path=clinical-management-and-monitoring-during-antifungal-therapy-of-the-hiv-infected-patient-with-cryptococcal-meningoencephalitis\" class=\"medical medical_review\">&quot;Clinical management and monitoring during antifungal therapy of the HIV-infected patient with cryptococcal meningoencephalitis&quot;</a>.)</p><p>The pathogenesis, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-seronegative patients will be reviewed here. Other issues related to <em>C. neoformans</em> infection are discussed separately. <em>Cryptococcus gattii</em> infection is also presented separately. (See <a href=\"topic.htm?path=microbiology-and-epidemiology-of-cryptococcus-neoformans-infection\" class=\"medical medical_review\">&quot;Microbiology and epidemiology of Cryptococcus neoformans infection&quot;</a> and <a href=\"topic.htm?path=cryptococcus-neoformans-treatment-of-meningoencephalitis-and-disseminated-infection-in-hiv-seronegative-patients\" class=\"medical medical_review\">&quot;Cryptococcus neoformans: Treatment of meningoencephalitis and disseminated infection in HIV seronegative patients&quot;</a> and <a href=\"topic.htm?path=cryptococcus-neoformans-infection-outside-the-central-nervous-system\" class=\"medical medical_review\">&quot;Cryptococcus neoformans infection outside the central nervous system&quot;</a> and <a href=\"topic.htm?path=cryptococcus-gattii-infection-microbiology-epidemiology-and-pathogenesis\" class=\"medical medical_review\">&quot;Cryptococcus gattii infection: Microbiology, epidemiology, and pathogenesis&quot;</a> and <a href=\"topic.htm?path=cryptococcus-gattii-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Cryptococcus gattii infection: Clinical features and diagnosis&quot;</a> and <a href=\"topic.htm?path=cryptococcus-gattii-infection-treatment\" class=\"medical medical_review\">&quot;Cryptococcus gattii infection: Treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>C. neoformans</em> causes infection following inhalation through the respiratory tract. The organism disseminates hematogenously and has a propensity to localize to the central nervous system (CNS). The basis for the tropism for the CNS is uncertain, but a number of hypotheses have been proposed:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The cerebrospinal fluid (CSF) is a favorable growth medium for the organism as it lacks the factors present in serum that inhibit cryptococcal growth [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/1\" class=\"abstract_t\">1</a>]. In the serum, the organism activates the alternative complement pathway, but complement activity in the CSF is very low [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/2\" class=\"abstract_t\">2</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dopamine levels in the CNS may promote cryptococcal virulence by serving as a substrate for melanin production by the organism [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/3\" class=\"abstract_t\">3</a>]. (See <a href=\"topic.htm?path=microbiology-and-epidemiology-of-cryptococcus-neoformans-infection\" class=\"medical medical_review\">&quot;Microbiology and epidemiology of Cryptococcus neoformans infection&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Production of <a href=\"topic.htm?path=mannitol-drug-information\" class=\"drug drug_general\">mannitol</a> by the organism may contribute to brain edema and inhibit phagocyte function [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/4\" class=\"abstract_t\">4</a>].</p><p/><p>The inflammatory response in the brain is generally milder than that seen in bacterial meningoencephalitis. The inflammatory cell infiltrate is predominantly comprised of mononuclear cells with occasional polymorphonuclear leukocytes. In general, involvement of the brain is diffuse, but localized infection (ie, cryptococcoma) can also occur.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most patients with cryptococcal meningitis are immunocompromised. The most common forms of immunosuppression other than HIV include glucocorticoid therapy, solid organ transplantation, cancer (particularly hematologic malignancy), and other conditions such as sarcoidosis and hepatic failure. In a multicenter retrospective study of 157 cases of central nervous system cryptococcosis in HIV-negative patients, 30 percent had no apparent underlying condition [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/5\" class=\"abstract_t\">5</a>].</p><p>Other issues related to the epidemiology of cryptococcal infection are discussed in detail separately. (See <a href=\"topic.htm?path=microbiology-and-epidemiology-of-cryptococcus-neoformans-infection\" class=\"medical medical_review\">&quot;Microbiology and epidemiology of Cryptococcus neoformans infection&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Clinical presentation of cryptococcal meningoencephalitis in HIV-seronegative patients is variable. Some patients have symptoms for up to several months prior to diagnosis, whereas others present with an acute illness of only a few days. Most patients present with signs and symptoms of subacute meningoencephalitis; fever is observed in approximately 50 percent of cases [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/5,6\" class=\"abstract_t\">5,6</a>]. Typically, headache, lethargy, personality changes, and memory loss develop over two to four weeks. Patients may also present with disseminated disease. (See <a href=\"topic.htm?path=cryptococcus-neoformans-infection-outside-the-central-nervous-system\" class=\"medical medical_review\">&quot;Cryptococcus neoformans infection outside the central nervous system&quot;</a>.)</p><p>Among solid organ transplant recipients, cryptococcal infection occurs in an average of 2.8 percent of patients [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/7,8\" class=\"abstract_t\">7,8</a>]. The median time to disease onset is 21 months after transplantation; 68 percent of cases occur &gt;1 year after transplantation. Central nervous system involvement and disseminated infection have been documented in 52 to 61 percent of patients with cryptococcal infection [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/7,9\" class=\"abstract_t\">7,9</a>]. Approximately 25 percent of transplant recipients with <em>C. neoformans</em> disease have fungemia [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/7,10\" class=\"abstract_t\">7,10</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diagnosis of cryptococcal meningoencephalitis can be challenging because of the subacute onset of symptoms and nonspecific presentation. The disease should be suspected in any immunocompromised patient with fever, headache, and signs or symptoms referable to the central nervous system (CNS). <em>C. neoformans</em> should also be considered in immunocompetent individuals presenting with subacute to chronic meningitis. A lumbar puncture is necessary to definitively diagnose cryptococcal meningoencephalitis, although this procedure should be delayed in the setting of focal neurologic signs, papilledema, or impaired mentation pending the results of radiographic imaging.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Cerebrospinal fluid</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lumbar puncture with measurement of the opening pressure and careful evaluation of the cerebrospinal fluid (CSF) with India ink <span class=\"nowrap\">and/or</span> cryptococcal antigen testing should suggest the diagnosis in most cases. Culture nearly always establishes the diagnosis.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The opening pressure may be markedly elevated. Almost 70 percent of AIDS patients with cryptococcal meningoencephalitis have opening pressures &gt;200 mmH<sub>2</sub>0 on the initial lumbar puncture [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/6\" class=\"abstract_t\">6</a>]. Increased intracranial pressure is observed less frequently in non&ndash;HIV-infected patients.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Examination of the CSF with India ink demonstrates encapsulated yeast forms in approximately 75 percent of HIV-infected patients and in 50 percent of non&ndash;HIV-infected patients [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/11,12\" class=\"abstract_t\">11,12</a>]. Gram stain is usually not sufficient since the organisms stain poorly and can be confused with host cells (<a href=\"image.htm?imageKey=ID%2F58455%7EID%2F63752%7EID%2F75483\" class=\"graphic graphic_picture graphicRef58455 graphicRef63752 graphicRef75483 \">picture 1A-C</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cell counts of the CSF are characteristically low in HIV-associated infection (0 to 50 <span class=\"nowrap\">cells/mm<sup>3</sup>),</span> and higher in non-HIV cases (20 to 200 <span class=\"nowrap\">cells/mm<sup>3</sup>)</span>. Mononuclear cells predominate in both HIV-infected and noninfected patients (50 to 80 percent).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Low glucose levels and elevated protein levels are frequently observed. Inflammatory cell counts have a lymphocytic predominance. Some patients present with normal CSF protein and glucose values [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/13\" class=\"abstract_t\">13</a>].</p><p/><p>The diagnosis of cryptococcal meningoencephalitis is established by culturing the organism from the CSF. Cultures are positive in about 90 percent of non-AIDS patients. <em>C. neoformans</em> usually takes three to five days to grow in the laboratory. At least 3 to 5 mL of CSF should be used for culture; the yield may be increased by culturing more than 15 mL of CSF [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/11,14\" class=\"abstract_t\">11,14</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Cryptococcal antigen</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>CSF cryptococcal antigen testing is an important adjunct to CSF culture for establishing the diagnosis of cryptococcal meningoencephalitis. Results of the antigen test can be obtained from most laboratories very soon after the lumbar puncture is performed. A positive antigen test suggests the presence of cryptococcal infection before the cultures results are complete. The antigen test is very sensitive and specific in the CSF. In a study of four latex agglutination test assays and one enzyme-linked immunoassay, all performed well, with sensitivities ranging from 93 to 100 percent and specificities of 93 to 98 percent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/15\" class=\"abstract_t\">15</a>]. More recently, a lateral flow assay has been developed for cryptococcal antigen detection, which is inexpensive, easy to perform, and accurate [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/16\" class=\"abstract_t\">16</a>]. (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-infected-patients#H7\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of Cryptococcus neoformans meningoencephalitis in HIV-infected patients&quot;, section on 'Cryptococcal antigen (CrAg)'</a>.)</p><p>Serum cryptococcal antigen testing in patients without HIV infection cannot be used to rule out cryptococcal meningoencephalitis, as the sensitivity is lower than in HIV-infected patients. Among organ transplant recipients, patients with CNS or disseminated cryptococcosis are more likely to have a positive serum cryptococcal antigen result than patients with pulmonary disease [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/10\" class=\"abstract_t\">10</a>]. (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-infected-patients#H7\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of Cryptococcus neoformans meningoencephalitis in HIV-infected patients&quot;, section on 'Cryptococcal antigen (CrAg)'</a>.)</p><p>The cryptococcal antigen can be quantified by evaluating serial dilutions of CSF or serum. The height of the antigen titer generally correlates with the burden of organisms. However, serial measurement of antigen titers is not a reliable indicator of response to therapy.</p><p>False-positive serum cryptococcal antigen tests can occur in the setting of infections due to the fungus <em>Trichosporon asahii</em> (formerly <em>T. beigelii</em>) or the bacterial genera <em>Stomatococcus</em> or <em>Capnocytophaga </em>[<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/17-19\" class=\"abstract_t\">17-19</a>]. False-positive CSF cryptococcal antigen results have been reported rarely following exposure of samples to disinfectants or soap or after samples were placed into an anaerobic transport vial [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/20-22\" class=\"abstract_t\">20-22</a>]. False-negative serum cryptococcal antigen tests can occur with samples that contain a large amount of antigen (the prozone phenomenon) if the laboratory is using a latex agglutination assay and doesn't pretreat the sample with pronase [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/15\" class=\"abstract_t\">15</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Extraneural cultures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of cryptococcal meningoencephalitis is occasionally made by recovering <em>C. neoformans</em> from an extraneural site before CNS disease is suspected. This is especially true in patients with HIV infection who have a high likelihood of extraneural disease involving the respiratory tract, urinary tract, or bloodstream at the same time as CNS infection. As an example, blood cultures have been positive for cryptococci in approximately two-thirds of HIV-associated cases of meningoencephalitis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/14\" class=\"abstract_t\">14</a>].</p><p>Therefore, lumbar puncture should be considered for patients with positive serum cryptococcal antigen or extraneural culture to rule out CNS involvement. Immunocompetent individuals with only pulmonary involvement who have no CNS signs or symptoms may not require a lumbar puncture prior to treatment.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Radiography</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Radiographic imaging of the brain with computed tomography (CT) or magnetic resonance imaging (MRI) prior to lumbar puncture is important in the setting of focal neurologic signs, papilledema, or impaired mentation. MRI is more effective than CT for identifying CNS cryptococcal lesions [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/23\" class=\"abstract_t\">23</a>].</p><p>Radiographic images frequently show no abnormality or cerebral atrophy without obstruction or other pathology [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/24\" class=\"abstract_t\">24</a>]. Less commonly, hydrocephalus may be seen. Mass lesions are seen in about 10 percent of patients with CNS cryptococcal infections [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/6\" class=\"abstract_t\">6</a>].</p><p>Some brain lesions persist radiographically for long periods even in those who have had a good clinical response to therapy [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/25\" class=\"abstract_t\">25</a>]. Lesions that develop surrounding edema during effective therapy are typically due to an immunologic response associated with control of infection, the so-called immune reconstitution inflammatory syndrome [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/26\" class=\"abstract_t\">26</a>]. (See <a href=\"topic.htm?path=immune-reconstitution-inflammatory-syndrome#H10\" class=\"medical medical_review\">&quot;Immune reconstitution inflammatory syndrome&quot;, section on 'IRIS associated with preexisting cryptococcal infection'</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Cryptococcus neoformans</em> meningoencephalitis is the most frequently encountered manifestation of cryptococcosis. The term &quot;meningoencephalitis&quot; is more appropriate than &quot;meningitis&quot; since histopathological examination has demonstrated that the brain parenchyma is almost always involved. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>C. neoformans</em> causes infection following inhalation through the respiratory tract. The organism disseminates hematogenously and has a propensity to localize to the central nervous system. The inflammatory response in the brain is generally milder than that seen in bacterial meningoencephalitis. The inflammatory cell infiltrate is predominantly comprised of mononuclear cells with occasional polymorphonuclear leukocytes. In general, involvement of the brain is diffuse, but localized infection (ie, cryptococcoma) can also occur. (See <a href=\"#H2\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most patients with cryptococcal meningitis are immunocompromised. The most common forms of immunosuppression other than HIV include glucocorticoid therapy, solid organ transplantation, cancer (particularly hematologic malignancy), and other conditions such as sarcoidosis and hepatic failure. (See <a href=\"#H3\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical presentation is variable. Some patients have symptoms for up to several months prior to diagnosis, whereas others present with an acute illness of only a few days. Fever is observed in approximately 50 percent of cases. Typically, headache, lethargy, personality changes, and memory loss develop over two to four weeks. Patients may also present with disseminated disease (eg, &gt;1 noncontiguous site). (See <a href=\"#H4\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A lumbar puncture is necessary for diagnosis of cryptococcal meningoencephalitis. The opening pressure should be measured, along with India ink evaluation, cryptococcal antigen testing, fungal culture, and routine spinal fluid studies. The diagnosis is established definitively by culturing the organism from the spinal fluid. (See <a href=\"#H6\" class=\"local\">'Cerebrospinal fluid'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum cryptococcal antigen testing is useful for evaluation of patients without HIV infection, although a negative result cannot be used to rule out cryptococcal meningoencephalitis. The height of the antigen titer generally correlates with the burden of organisms, although serial measurement of antigen titers is not a reliable indicator of response to therapy. (See <a href=\"#H7\" class=\"local\">'Cryptococcal antigen'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Radiographic imaging of the brain with computed tomography or magnetic resonance imaging prior to lumbar puncture is important in the setting of focal neurologic signs, papilledema, or impaired mentation. Radiographic images frequently show no abnormality or cerebral atrophy without obstruction or other pathology. Less commonly, hydrocephalus may be seen. Mass lesions are seen in about 10 percent of patients with central nervous system cryptococcal infections. (See <a href=\"#H9\" class=\"local\">'Radiography'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/1\" class=\"nounderline abstract_t\">Igel HJ, Bolande RP. Humoral defense mechanisms in cryptococcosis: substances in normal human serum, saliva, and cerebrospinal fluid affecting the growth of Cryptococcus neoformans. J Infect Dis 1966; 116:75.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/2\" class=\"nounderline abstract_t\">Diamond RD, May JE, Kane MA, et al. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol 1974; 112:2260.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/3\" class=\"nounderline abstract_t\">Kwon-Chung KJ, Rhodes JC. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun 1986; 51:218.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/4\" class=\"nounderline abstract_t\">Wong B, Perfect JR, Beggs S, Wright KA. Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis. Infect Immun 1990; 58:1664.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/5\" class=\"nounderline abstract_t\">Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001; 33:690.</a></li><li class=\"breakAll\">Cox, GM, Perfect, JR. Cryptococcus neoformans var neoformans and gattii and Trichosporon species. In: Topley and Wilson's Microbiology and Microbial Infections, 9th ed, Ajello, Edward (Ed), Arnold Press, London 1997.</li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/7\" class=\"nounderline abstract_t\">Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001; 7:375.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/8\" class=\"nounderline abstract_t\">Vilchez RA, Fung J, Kusne S. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant 2002; 2:575.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/9\" class=\"nounderline abstract_t\">Shaariah W, Morad Z, Suleiman AB. Cryptococcosis in renal transplant recipients. Transplant Proc 1992; 24:1898.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/10\" class=\"nounderline abstract_t\">Singh N, Alexander BD, Lortholary O, et al. Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis 2007; 195:756.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/11\" class=\"nounderline abstract_t\">Dismukes WE, Cloud G, Gallis HA, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987; 317:334.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/12\" class=\"nounderline abstract_t\">Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med 1974; 80:176.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/13\" class=\"nounderline abstract_t\">Shaunak S, Schell WA, Perfect JR. Cryptococcal meningitis with normal cerebrospinal fluid. J Infect Dis 1989; 160:912.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/14\" class=\"nounderline abstract_t\">Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 1992; 326:83.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/15\" class=\"nounderline abstract_t\">Tanner DC, Weinstein MP, Fedorciw B, et al. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 1994; 32:1680.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/16\" class=\"nounderline abstract_t\">Hansen J, Slechta ES, Gates-Hollingsworth MA, et al. Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid. Clin Vaccine Immunol 2013; 20:52.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/17\" class=\"nounderline abstract_t\">Chanock SJ, Toltzis P, Wilson C. Cross-reactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigen. Lancet 1993; 342:1119.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/18\" class=\"nounderline abstract_t\">McManus EJ, Jones JM. Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection. J Clin Microbiol 1985; 21:681.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/19\" class=\"nounderline abstract_t\">Westerink MA, Amsterdam D, Petell RJ, et al. Septicemia due to DF-2. Cause of a false-positive cryptococcal latex agglutination result. Am J Med 1987; 83:155.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/20\" class=\"nounderline abstract_t\">Blevins LB, Fenn J, Segal H, et al. False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps. J Clin Microbiol 1995; 33:1674.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/21\" class=\"nounderline abstract_t\">Boom WH, Piper DJ, Ruoff KL, Ferraro MJ. New cause for false-positive results with the cryptococcal antigen test by latex agglutination. J Clin Microbiol 1985; 22:856.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/22\" class=\"nounderline abstract_t\">Wilson DA, Sholtis M, Parshall S, et al. False-positive cryptococcal antigen test associated with use of BBL Port-a-Cul transport vials. J Clin Microbiol 2011; 49:702.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/23\" class=\"nounderline abstract_t\">Charlier C, Dromer F, L&eacute;v&ecirc;que C, et al. Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS One 2008; 3:e1950.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/24\" class=\"nounderline abstract_t\">Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000; 30:47.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/25\" class=\"nounderline abstract_t\">Hospenthal DR, Bennett JE. Persistence of cryptococcomas on neuroimaging. Clin Infect Dis 2000; 31:1303.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-seronegative-patients/abstract/26\" class=\"nounderline abstract_t\">Einsiedel L, Gordon DL, Dyer JR. Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman. Clin Infect Dis 2004; 39:e78.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2447 Version 13.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H10\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">PATHOGENESIS</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">EPIDEMIOLOGY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">CLINICAL MANIFESTATIONS</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">DIAGNOSIS</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">Cerebrospinal fluid</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Cryptococcal antigen</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Extraneural cultures</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Radiography</a></li></ul></li><li><a href=\"#H10\" id=\"outline-link-H10\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/2447|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/58455\" class=\"graphic graphic_picture\">- Cryptococcus neoformans in CSF</a></li><li><a href=\"image.htm?imageKey=ID/63752\" class=\"graphic graphic_picture\">- Cryptococcus neoformans India ink</a></li><li><a href=\"image.htm?imageKey=ID/75483\" class=\"graphic graphic_picture\">- Cryptococcus neoformans Sabouraud agar</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-management-and-monitoring-during-antifungal-therapy-of-the-hiv-infected-patient-with-cryptococcal-meningoencephalitis\" class=\"medical medical_review\">Clinical management and monitoring during antifungal therapy of the HIV-infected patient with cryptococcal meningoencephalitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cryptococcus-gattii-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">Cryptococcus gattii infection: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cryptococcus-gattii-infection-microbiology-epidemiology-and-pathogenesis\" class=\"medical medical_review\">Cryptococcus gattii infection: Microbiology, epidemiology, and pathogenesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cryptococcus-gattii-infection-treatment\" class=\"medical medical_review\">Cryptococcus gattii infection: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cryptococcus-neoformans-infection-outside-the-central-nervous-system\" class=\"medical medical_review\">Cryptococcus neoformans infection outside the central nervous system</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cryptococcus-neoformans-treatment-of-meningoencephalitis-and-disseminated-infection-in-hiv-seronegative-patients\" class=\"medical medical_review\">Cryptococcus neoformans: Treatment of meningoencephalitis and disseminated infection in HIV seronegative patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-infected-patients\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of Cryptococcus neoformans meningoencephalitis in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immune-reconstitution-inflammatory-syndrome\" class=\"medical medical_review\">Immune reconstitution inflammatory syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=microbiology-and-epidemiology-of-cryptococcus-neoformans-infection\" class=\"medical medical_review\">Microbiology and epidemiology of Cryptococcus neoformans infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-cryptococcus-neoformans-meningoencephalitis-in-hiv-infected-patients\" class=\"medical medical_review\">Treatment of Cryptococcus neoformans meningoencephalitis in HIV-infected patients</a></li></ul></div></div>","javascript":null}